(5) These discoveries were translated into two new therapies that attenuate atherosclerosis; that is, the progression of atherosclerotic plaque formation might be retarded by inhibiting the miR-107–HIF-1α–MiD51–Drp1 or MiD49–Drp1 pathway. This evidence concerns the gene DNM1L and atherosclerosis.